Key facts
- This page summarizes Graig Springer's Form 4 filing for Hoth Therapeutics, Inc. (HOTH).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Jan 2025, 16:15.
Graig Springer - 14 Jan 2025 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)
- Reporting relationship
- Director
- Issuer ticker
- HOTH
- Reported as of
- 14 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jan 2025, 16:15:06 UTC
- Prior SEC filing
- 21 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Hayley Springer as Attorney-In-Fact for Graig Springer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Graig Springer filed Form 4 for Hoth Therapeutics, Inc. (HOTH) on 15 Jan 2025.
Change
- Previous filing in this sequence was filed on 21 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HOTH
transaction
Derivative
Options
Award
- Transaction value
- $0
- Shares
- +70,000
- Change %
- Price
- $0.000000
- Shares after
- 70,000
- Date
- 14 Jan 2025
- Ownership
- See footnote
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $1.55
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The options were issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.
Footnote F2
Held beneficially by the wife of the Reporting Person.